Latest News

Extension of Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)
Extension of public comment period on the changed notice of proposed rulemaking establishing a  No Significant Risk Level: 4-Methylimidazole (4-MEI).
Oct 24, 2011, Program: Proposition 65
Carcinogen Identification Committee Meeting Scheduled for October 12 and 13, 2011
Announcement of the October 12th and 13th2011 CIC meeting and hazard ID materials for fluoride and its salts, and tris(1,3-Dichloro-2-Propyl) phosphate.  Both will be considered for listing at the October 2011 meeting.
Oct 12, 2011, Program: Proposition 65
Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)
Comment period for the Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI).
Oct 7, 2011, Program: Proposition 65
Notice of Augmentation of Record and 2nd Modification of Text of Proposed Regulation Title 22, California Code of Regulations, Sections 69401 Through 69407 Green Chemistry Hazard Traits for California’s Toxics Information Clearinghouse
The Office of Environmental Health Hazard Assessment (OEHHA) is providing a notice of changes made to the proposed regulation: Title 22, California Code of Regulations, sections 69401 through 69407. OEHHA has reviewed the comments it received in this second comment period and is now proposing amendments to the modified proposed regulation and is augmenting the administrative record.  A copy of the text of the amended proposed regulation is attached.
Oct 7, 2011, Program: Risk Assessment
Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)
The proposed NSRL for 4-MEI has been changed from 16 to to 29 micrograms per day.
Oct 7, 2011, Program: Proposition 65
Comment Period - Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil
Notice to propose establishment of a specific regulatory level posing no significant risk for imazalil and amend Title 27, California Code of Regulations, section 25705.
Sep 23, 2011, Program: Proposition 65
Notice of Withdrawal and Resubmittal of Proposed Rulemaking Amendment to Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil
A notice to establish a specific regulatory level posing no significant risk for imazalil was posted on the OEHHA website and published in the CRNR on September 9, 2011. OEHHA is withdrawing that notice because a number of non-substantive, clarifying changes to the notice were required.
Sep 23, 2011, Program: Proposition 65
Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil
Proposal to add a NSRL for imazalil of 11ug/day.
Sep 23, 2011, Program: Proposition 65
Comments on Proposed Modified Regulation
OEHHA received the following comments after OEHHA provided notice on July 29, 2011 of modification of text of proposed regulation - Title 22, California Code of Regulations, Sections 69401 Through 69406 - Green Chemistry Toxics Information Clearinghouse Identification of Hazard Traits, Endpoints and Other Relevant Data for Inclusion in the Toxics Information Clearinghouse.
Sep 22, 2011, Program: Risk Assessment
Notice of Intent to List Chemicals: Estrogen–progestogen (combined) used as menopausal therapy, Etoposide, Etoposide in combination with cisplatin and bleomycin, Methyl isobutyl ketone, MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture)
Intent to list chemicals by the labor code mechanism: Estrogen–progestogen (combined) used as menopausal therapy, etoposide, etoposide in combination with cisplatin and bleomycin, methyl isobutyl ketone, MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture).
Sep 16, 2011, Program: Proposition 65

Pages